Numerous people take ibuprofen and other non-steroidal anti-inflammatory drugs (NSAIDs) to relieve unrelenting pain. Sadly, these drugs only offer short-term relief. Additionally, a new study indicates that they also increase the risk of heart problems when taken for extended periods of time.
Deadly Heart Attacks
Routinely used to treat acute and chronic pain, NSAIDs are known for causing gastrointestinal bleeding. Now, new research suggests they can also dramatically increase a person’s risk of serious heart problems. Appearing in The Lancet, the study centered on data associated with more than 350,000 patients who had all taken some type of non-steroidal anti-inflammatory drug for more than 12 months. After looking at patient medical records, researchers found that a large portion of these patients suffered what they called “avoidable heart attacks.” In fact, so many experienced problems; the researchers determined that the NSAIDs doubled each user’s risk of heart failure.
Wake Up Call for TMD Sufferers
Since they typically endure some form of chronic pain, TMD sufferers often rely on common pain relievers to get through the day. According to this new research, this could put them at risk for heart failure. Ultimately, since NSAIDs provide only temporary pain relief, they aren’t the ideal way to treat temporomandibular joint disorder. Additionally, it’s clear that they come with some serious risks that may outweigh whatever benefits they offer.
A Safer, Smarter Approach
TMJ disorder doesn’t have to be a lifelong problem. Usually caused by a misaligned bite, temporomandibular joint disorder is treatable. By providing a treatment strategy which targets the root cause of TMD, Dr. Berry offers his patients lasting relief from chewing difficulties, headaches, jaw popping, pain and other symptoms related to TMJ disorder.
Why put your health at risk just for a couple of hours of pain relief, when you can get safe, non-medicinal TMD relief? Please call (303) 691-0267 at the TMJ Therapy & Sleep Center of Colorado in Denver today.